STATEMENT OF USE - TO EXAMINER
to examiner
on 18 Nov 2024
Last Applicant/ Owned by
919 E. Hillsdale Blvd., Suite 250
Foster City
CA
94404
Serial Number
90658752 filed on 20th Apr 2021
Registration Number
N/A
Correspondent Address
Sharon R. Smith
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
RYTELO
Pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
First Use Date in General
24th Jun 2024
First Use Date in Commerce
24th Jun 2024
Mark Details
Serial Number
No 90658752
Mark Type
No Service/Collective Mark
Attorney Docket Number
No GER-614
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Nov 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Nov 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Nov 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 18th Nov 2024 | SOU EXTENSION 4 GRANTED |
| 13th Sep 2024 | SOU TEAS EXTENSION RECEIVED |
| 13th Sep 2024 | SOU EXTENSION 4 FILED |
| 09th Aug 2024 | TEAS STATEMENT OF USE RECEIVED |
| 09th Aug 2024 | USE AMENDMENT FILED |
| 08th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th Feb 2024 | SOU TEAS EXTENSION RECEIVED |